DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMLAMSRAFoundationGP

Gastro-oesophageal reflux in infancy

Recognise physiological regurgitation, identify reflux disease and alternative pathology, avoid unnecessary tests and acid suppression, use feed assessment and stepwise management, and give families safe sleep and escalation advice.

!
Obstruction, bleeding or systemic illness

Bilious vomiting, haematemesis with instability, abdominal distension, shock, sepsis features or acute neurological abnormality is not uncomplicated reflux.

Action: Stabilise airway, breathing and circulation, check glucose and hydration, stop oral feeds if obstruction is suspected, obtain urgent paediatric or surgical assessment and investigate according to the presentation. Projectile vomiting in a young infant needs same-day evaluation for pyloric stenosis; significant dehydration or electrolyte disturbance needs controlled correction.

Open the sections you need. The overview is shown first.
01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Transient lower oesophageal sphincter relaxations allow gastric contents to return into the oesophagus. Liquid feeds, frequent supine periods and a short intra-abdominal oesophagus make this especially common in infancy.

Reflux becomes gastro-oesophageal reflux disease when it causes troublesome symptoms or complications such as feeding difficulty, oesophagitis or impaired growth. Crying alone is too nonspecific to establish this.

Clinical assessment quantifies frequency, force, colour and content of vomit, relationship to feeds, pain, respiratory symptoms, stool, urine and growth. Ask about exact formula preparation and volume.

A complete observed feed may show excessive flow, air swallowing, overfeeding, poor attachment or dysphagia. Correcting mechanics has more value than switching repeatedly between formulas.

Thickening reduces visible regurgitation but does not necessarily change oesophageal acid exposure. It can cause constipation and must be used with safe product-specific preparation.

Alginate creates a viscous raft and may reduce episodes. Infant products have weight- and feed-dependent instructions and sodium exposure; prescribe by the current formulary or SmPC rather than memory.

Acid suppression does not stop reflux events. It changes acidity and can increase infection risk; use only for a defined symptom complex, with a stop date and response review.

Sleep positioning is governed by sudden-infant-death prevention. Apparent post-feed comfort does not justify prone sleep or devices that can cause entrapment.

Specialist investigation is selected to answer a question: endoscopy for suspected mucosal disease, contrast imaging for anatomy rather than reflux severity, and pH-impedance for symptom association.

Parental observation is valuable. A video may clarify vomiting pattern, but green colour, physiological compromise or other red flags still require direct assessment.

Key points

  • Gastro-oesophageal reflux is passage of gastric contents into the oesophagus and is common in infancy. In a thriving comfortable baby, visible regurgitation is usually physiological and resolves by 12–18 months.
  • Diagnose uncomplicated reflux clinically. Do not routinely investigate a well infant with effortless regurgitation, normal examination and satisfactory growth.
  • First-line for a breastfed infant with frequent regurgitation and marked distress is a skilled breastfeeding assessment addressing transfer, oversupply, positioning and attachment while continuing breastfeeding.
  • For a formula-fed infant, review feeding history and volume first. Reduce only if excessive, then trial smaller more frequent feeds while preserving the appropriate total daily amount.
  • If distress persists, trial a thickened formula. If this fails, stop the thickener and consider an alginate for 1–2 weeks, with review; do not combine alginate with an already thickened feed without specialist advice.
  • For a breastfed infant with persistent distress after assessment, NICE allows an alginate trial for 1–2 weeks while breastfeeding continues.
  • Do not prescribe proton-pump inhibitors or H2-receptor antagonists for isolated visible regurgitation. Consider a time-limited 4-week acid-suppression trial only when regurgitation accompanies feeding difficulty, distress or faltering growth after reassessment.
  • Always place the infant supine for every sleep on a firm flat surface. Do not use prone or side sleep, cot elevation, wedges or positioners as reflux treatment.
  • Cow's-milk protein allergy, UTI, gastroenteritis, overfeeding, dysphagia, pyloric stenosis and obstruction can imitate reflux; history and red flags decide the pathway.
  • pH-impedance monitoring is a specialist reference test when correlation of acid and non-acid reflux with persistent symptoms will alter care; it is not a routine confirmation test.
  • Explain the natural history and agree what deterioration means. Family exhaustion deserves practical support even when medication is unnecessary.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
01

Developmental physiology

Frequent transient sphincter relaxation, liquid diet and short oesophageal anatomy allow common effortless regurgitation. in otherwise healthy thriving infants.

02

Feeding factors

Excess volume, rapid flow, aerophagia and ineffective breast or bottle technique can increase gastric distension and visible reflux.

03

Predisposing disease

Prematurity, neurological impairment, repaired oesophageal atresia, diaphragmatic disease and chronic respiratory conditions increase clinically important reflux risk.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
  1. 1
    Retrograde flow

    Transient lower oesophageal sphincter relaxation permits liquid gastric contents to enter the oesophagus or mouth. after or between milk feeds.

  2. 2
    Mucosal exposure

    Prolonged acid or pepsin contact can inflame oesophageal mucosa, causing pain, feeding avoidance or bleeding in true disease.

  3. 3
    Airway interaction

    Reflux and swallowing dysfunction may coexist, but respiratory symptoms do not prove aspiration of refluxate without targeted assessment.

  4. 4
    Natural maturation

    More upright posture, solid food and sphincter maturation reduce events across the first 12–18 months of developmental change.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Vomiting phenotype

Record onset, frequency, force, colour, blood, volume, timing and whether vomiting is effortless, progressive, painful or nocturnal.

Feed assessment

Quantify milk, formula recipe, teat flow, feed duration and supplements and observe coordination, attachment, distress and satiety.

Growth and hydration

Plot serial weight and length and examine urine output, mucosa, fontanelle, perfusion and nutritional state.

Associated systems

Ask about fever, stool, urine, eczema, cough, choking, apnoea and neurological change and examine chest, abdomen and neurology.

Family effect

Assess sleep, caregiver exhaustion, anxiety and ability to implement a plan, validating burden without medicalising normal regurgitation.

Red flags requiring action

  • Bilious green vomit indicates possible intestinal obstruction and requires urgent surgical assessment.
  • Progressively forceful or projectile vomiting, especially before 2 months with hunger and poor growth, suggests pyloric stenosis.
  • Haematemesis, melaena, blood in stool, abdominal distension or a palpable mass is not explained by simple reflux.
  • Fever, lethargy, bulging fontanelle, seizures, dysuria or persistent inconsolability suggests infection, neurological or other systemic disease.
  • Coughing, choking, cyanosis, wet breathing or recurrent pneumonia during feeds suggests aspiration or swallowing dysfunction.
  • Onset after 8 weeks, persistent vomiting beyond 1 year, faltering growth or feeding refusal warrants reassessment for another diagnosis.
05InvestigationsWhat to request, why it matters and how to interpret it.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    First-line: clinical and feeding assessmentFirst stepFirst line
    Why
    Distinguish physiological reflux, disease and red-flag mimics.
    Interpretation and limitations
    A thriving comfortable infant without red flags needs no test; abnormal force, colour, growth or examination directs investigation.
  2. 02
    Targeted ultrasound
    Why
    Assess suspected pyloric stenosis in a young infant with progressive projectile non-bilious vomiting.
    Interpretation and limitations
    Pyloric measurements and dynamic failure of gastric passage are interpreted by paediatric radiology with clinical and biochemical findings.
  3. 03
    Contrast imaging
    Why
    Define suspected anatomical obstruction or malrotation.
    Interpretation and limitations
    It evaluates anatomy and is not a measure of reflux severity because reflux may be seen incidentally.
  4. 04
    Reference test: 24-hour pH-impedance monitoring
    Why
    Correlate persistent symptoms with acid and non-acid reflux when this will change specialist management.
    Interpretation and limitations
    Interpret reflux burden and symptom association in clinical context; a negative association prompts alternative diagnoses.
  5. 05
    Endoscopy with biopsy
    Why
    Assess suspected oesophagitis, bleeding, stricture or eosinophilic disease.
    Interpretation and limitations
    Mucosal and histological findings may demonstrate complications or another diagnosis; normal endoscopy does not exclude all reflux.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
01

Pyloric stenosis or obstruction

Projectile non-bilious vomiting or bilious vomiting respectively requires urgent anatomical assessment. rather than empirical reflux treatment.

02

Cow's-milk protein allergy

Eczema, blood or mucus in stool, diarrhoea or reproducible immune symptoms may support allergy, but reflux alone does not.

03

Infection

UTI, gastroenteritis, sepsis and meningitis may cause vomiting with fever, lethargy, urine or neurological findings. that distinguish it from uncomplicated reflux.

04

Feeding and swallowing disorder

Cough, wet breathing, colour change, prolonged feeds or recurrent pneumonia points to oropharyngeal dysfunction. requiring targeted feeding assessment.

05

Metabolic or intracranial disease

Hypoglycaemia, metabolic decompensation or raised intracranial pressure produces systemic, neurological or developmental clues. that demand urgent targeted investigation.

07ManagementImmediate care, first-line treatment, alternatives and escalation.
01WellReassure and supportFirst stepRegurgitation is effortless, growth and examination are normal and no red flag is present.
  1. 1Explain natural resolution and continue responsive milk feeding.
  2. 2Observe technique and avoid excessive volumes while maintaining nutritional needs.
  3. 3Give safe-sleep and explicit return advice; do not prescribe routine acid suppression.
02BreastfedAssess breastfeeding firstFrequent regurgitation causes marked distress in a breastfed infant.
  1. 1Arrange a skilled complete breastfeeding assessment and correct modifiable transfer issues.
  2. 2If persistent, consider an alginate trial for 1–2 weeks while breastfeeding continues.
  3. 3Stop or continue only after review of objective benefit and adverse effects.
03FormulaUse the NICE sequenceA formula-fed infant has frequent regurgitation with marked distress.
  1. 1Review volume; reduce only if excessive, then try smaller more frequent feeds preserving an appropriate daily total.
  2. 2Trial an appropriate thickened infant formula if symptoms persist.
  3. 3If unsuccessful, stop thickener and trial alginate for 1–2 weeks, then review.
04DiseaseReassess before acid suppressionRegurgitation accompanies feeding difficulty, marked distress or faltering growth.
  1. 1AlternativeRecheck red flags, feeding, allergy and alternative diagnoses.
  2. 2Consider a 4-week PPI or H2-receptor-antagonist trial only within NICE indications and age-appropriate prescribing.
  3. 3EscalationStop if ineffective and refer or investigate according to persistent features rather than escalating indefinitely.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
01

Oesophagitis

Persistent mucosal injury may cause pain, feeding refusal, haematemesis or rarely stricture. when exposure is persistent and clinically significant.

02

Faltering growth

Losses, feeding avoidance or an underlying disorder can prevent adequate energy intake. over repeated feeds and days.

03

Respiratory morbidity

Coexisting aspiration or airway disease may cause cough, wheeze and recurrent infection and needs specific evaluation.

04

Treatment harm

Unnecessary restriction, thickening or acid suppression can cause constipation, nutritional compromise, infection or delayed alternative diagnosis.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.
  • Track growth, hydration, feed experience and red flags rather than counting spit-ups alone.
  • Review every thickener, alginate or acid-suppression trial at the stated interval with an explicit stop decision.
  • Monitor constipation and preparation error with thickened feeds or alginate.
  • Ask about cough, choking, recurrent chest symptoms and feeding duration as clues to dysphagia.
  • Reconfirm supine flat sleep and removal of wedges or positioners.
  • Review caregiver wellbeing and provide a clear point of contact if symptoms worsen.
  • Reconsider diagnosis when symptoms begin late or persist beyond expected maturation.
10Special situationsVariants, exceptions and circumstances that change the usual approach.

Visible reflux is not acid disease

A medicine that changes acidity does not stop the mechanical event and therefore does not treat uncomplicated posseting.

Green changes urgency

Bilious vomit is an obstruction signal regardless of how often an infant has previously regurgitated normally.

Sequence avoids overtreatment

NICE places feed assessment, volume correction and thickening before alginate in formula-fed infants with distress.

Sleep safety outranks positioning

Supine flat sleep remains the recommendation even when an infant appears to regurgitate after feeds.

Late onset reopens diagnosis

New vomiting after 8 weeks or persistence beyond infancy is less typical and merits assessment for another cause.

11Common pitfallsFrequent interpretation and management errors.
  1. 01

    Do not label all crying as reflux disease.

  2. 02

    Do not miss bilious or progressively projectile vomiting.

  3. 03

    Do not prescribe a PPI for isolated regurgitation.

  4. 04

    Do not combine thickened formula and alginate without specialist product advice.

  5. 05

    Do not reduce feed volume below nutritional need.

  6. 06

    Do not use cot elevation, wedges, prone or side sleep.

  7. 07

    Do not repeatedly switch formula without defining the indication.

  8. 08

    Do not continue an ineffective medication without revisiting the diagnosis.

Practice

Two practice questions

Question 1 of 20 correct
Paediatrics and child healthOriginal SBA

Initial management in breastfeeding

A thriving breastfed 6-week-old has frequent regurgitation with marked distress but no red flags. What is the best first step?

Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom